Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells

Acta Pharmacologica Sinica

Volumn 28, Issue 12, 2007, Pages 1968-1974

  Wang, Hao ^a   Tan, Sheng Shun ^a   Wang, Xin Yang ^a   Liu, Dong Hua ^a   Yu, Chun Shui ^a   Bai, Zhuan Li ^a   He, Da Lin ^a   Zhao, Jun ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Livin; Malignant melanoma; Proliferation; siRNA

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; DNA NUCLEOTIDYLEXOTRANSFERASE; LIVIN; PROCASPASE 3; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSFECTION; MELANOMA; NICK END LABELING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; FLOW CYTOMETRY; GENE SILENCING; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MELANOMA; NEOPLASM PROTEINS; RNA, SMALL INTERFERING;

EID: 36649017482     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00724.x     Document Type: Article

References (27)

1. Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 2001 276:3238 46.
2. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000 10:1359 66.
3. Lin JH, Deng G, Huang Q, Morser J. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun 2000 279:820 31.
4. Liu B, Han M, Wen JK, Wang L. Livin/ML-IAP as a new target for cancer treatment. Cancer Lett 2007 250:168 76.
5. Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, et al. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Cancer Res 2003 63:6340 9.
6. Gong J, Chen N, Zhou Q, Yang B, Wang Y, Wang X. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and meta-static melanomas. J Clin Pathol 2005 58:1081 5.
7. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001 411:494 8.
8. Izquierdo M. Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther 2005 12:217 27.
9. Li CY, Gao TW, Wang G, Han Z Y, Li TH, Liu YF. The effect of antisense tyrosinase-related protein 1 on melanocytes and malignant melanoma cells. Br J Dermatol 2004 150:1081 90.
10. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004 22:326 30.
11. Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D, Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett 2001 495:56 60.
12. -?Ct method. Methods 2001 25:402 8.
13. Du Y, Yin F, Liu C, Hu S, Wang J, Xie H, et al. Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway. Biochem Biophys Res Commun 2006 345:1092 8.
14. Zhang HZ, Wang Y, Gao P, Lin F, Liu L, Yu B, et al. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells. Cancer Biol Ther 2006 5:1457 61.
15. Nachmias B, Ashhab Y, Ben-Yehuda D. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 2004 14:231 43.
16. Fischer U, Schulze-Osthoff K. New approaches and therapeutics targeting apoptosis in disease. Pharmacol Rev 2005 57:187 215.
17. Kumar S. Caspase function in programmed cell death. Cell Death Differ 2007 14:32 43.
18. Kumar MV, Shirley R, Ma Y, Lewis RW. Role of genomics-based strategies in overcoming chemotherapeutic resistance. Curr Pharm Biotechnol 2004 5:471 80.
19. Shi Y. Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci 2004 13:1979 87.
20. Namkoong J, Martino JJ, Chen S. From existing therapies to novel targets: a current view on melanoma. Front Biosci 2006 11:2081 92.
21. Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 2002 30:1757 66.
22. Crnkovic-Mertens I, Hoppe-Seyler F, Butz K. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ ML-IAP/KIAP gene. Oncogene 2003 22:8330 6.
23. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001 411:342 8.
24. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004 73:39 85.
25. Pietenpol JA, Stewart ZA. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 2002 181-182:475 81.
26. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000 408:433 9.
27. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 2002 36:617 56.